SyntheticMR
- Company typePublic
- Founded2007
- HeadquartersLinköping, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
SyntheticMR firmographics
Firmographics- Name
- SyntheticMR
- Legal name
- SyntheticMR AB
- Website
- https://syntheticmr.com
- Company type
- Public
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
SyntheticMR industry classification
Industry- Product category
- Medical Imaging Software (Quantitative MRI)
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)
- akta.pro secondary industries
- SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF), Medical Imaging AI (HDAAAEAH), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
Keywords
Where SyntheticMR is headquartered
LocationHeadquarters
- HQ city
- Linköping
- HQ country
- Sweden
- HQ region
- Europe
Offices7 records
Markets served
SyntheticMR business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Software License Sales: SyMRI software sold as product packages (SyMRI NEURO, SyMRI MSK) through direct sales and channel partners. Revenue from software licenses, potentially recurring maintenance/upgrades.
- OEM Licensing (GE Healthcare - MAGiC): Customized version of SyMRI IMAGE marketed and sold by GE Healthcare under license agreement. Generates licensing/royalty revenue.
- Acquisition Integration (Combinostics): Acquired Combinostics Oy in January 2025 for EUR 4.3 million to integrate cNeuro platform and strengthen AI-based neuroimaging capabilities.
Go-to-market motion3 records
Distribution channels9 records
Marketing channels8 records
SyntheticMR product offering
Product offeringCore offering
SyntheticMR develops and markets SyMRI, a quantitative MRI software platform that produces multiple adjustable contrast-weighted images and absolute tissue property measurements (T1, T2, PD maps) plus automatic brain tissue and myelin segmentations from a single 5-minute MRI scan. The platform is sold in clinically focused packages (SyMRI NEURO for brain imaging, SyMRI MSK for knee and spine, SyMRI IMAGE / MAGiC standard package) and complemented by the cNeuro AI clinical decision-support platform (acquired from Combinostics Oy) for differential diagnosis of cognitive and neurodegenerative disorders.
Product overview
SyntheticMR develops and markets SyMRI, an innovative MRI software platform that delivers multiple adjustable contrast images and quantitative data from a single 5-minute scan. The product portfolio includes SyMRI NEURO (advanced brain imaging with automatic tissue segmentation and myelin quantification, CE-marked and FDA 510(k) cleared), SyMRI MSK (musculoskeletal imaging for knee and spine, CE-marked), and SyMRI IMAGE (standard package with multiple contrast images). The company also offers SyMRI 3D and SyMRI 15 as newer generations. Through its acquisition of Combinostics Oy in January 2025, SyntheticMR expanded to include the cNeuro AI-driven platform with modules for cMRI, cDSI, cPET, and cDAT, combining quantitative MRI with AI-powered clinical decision support for neurological diagnostics. A licensed version, MAGiC, is distributed by GE Healthcare under a license agreement.
Differentiator
Problem solved
Functional benefit
Brands
- SyMRI: Quantitative MRI software delivering multiple adjustable contrast images and quantitative data from a single scan. Available in different packages including SyMRI NEURO (brain imaging with tissue segmentation and volumetric measurements), SyMRI MSK (knee and spine imaging), and SyMRI IMAGE (general imaging).
- cNeuro
- MAGiC
- SyMap
Products and services
- SyMRI NEURO Advanced quantitative brain MRI software package that delivers multiple adjustable contrast-weighted images, automatic tissue segmentation (WM, GM, CSF, myelin), volumetric measurements, parametric T1/T2/PD maps and REMyDI myelin quantification from a single scan. CE-marked under EU MDR 2017/745 and FDA 510(k) cleared. Designed for neuroradiology departments, neurology departments and cognitive/memory clinics diagnosing and monitoring MS, dementia, brain tumors, ALS, stroke and pediatric neurological conditions.
- SyMRI MSK (Spine / Knee) Quantitative musculoskeletal MRI software package delivering multiple contrast-weighted images (T1W, T2W, PDW, STIR) and quantitative T1, T2 and PD maps for knee and spine anatomies in a single 6-minute acquisition. CE-marked. Used by orthopedic and MSK radiologists for cartilage, spine and spinal cord assessment.
- SyMRI IMAGE Standard quantitative MRI software package delivering up to 8 contrast-weighted images (T1W, T2W, T2W FLAIR, Double Inversion Recovery, Phase Sensitive Inversion Recovery) from a single 6-minute scan, designed to speed up clinical MRI workflow for general imaging use.
- MAGiC Customer-specific version of SyMRI IMAGE marketed and sold globally by GE Healthcare under a license agreement with SyntheticMR. Available on GE Healthcare's SIGNA MRI systems including SIGNA Pioneer. Generates licensing/royalty revenue for SyntheticMR through OEM distribution.
- cNeuro AI-driven clinical decision support platform acquired with Combinostics Oy in January 2025. Combines quantitative MRI data with clinical data to support differential diagnosis and disease progression prediction in cognitive disorders such as Alzheimer's and other dementias. Comprises the modules cMRI (automated MRI brain image analysis), cDSI (diagnostic support), cPET (PET image analysis) and cDAT (SPECT/DaTscan analysis), supporting interdisciplinary neurology, radiology and nuclear medicine workflows.
Quantifiable outcome
- 5-minute scan time vs. multiple conventional sequences
- +4 more outcomes
Companies that use SyntheticMR
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles2 records
SyntheticMR technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability7 records
Feature6 records
SyntheticMR partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- GE HealthcarecoreGE Healthcare markets and sells MAGiC, a customer-specific version of SyMRI IMAGE, under a license agreement. MAGiC is available on GE's SIGNA MRI systems including the SIGNA Pioneer. This is a flagship OEM partnership generating licensing revenue and global distribution through GE's installed base.
- Siemens HealthineerscoreSyMRI NEURO is available on syngo.via Open Apps from Siemens Healthineers. Collaboration has expanded from initial agreement to direct availability through Siemens Healthineers globally. Also integrated with Siemens Healthineers' Digital Ecosystem.
- Philips HealthcarecoreGlobal agreement for inclusion of SyMRI in Philips' third party product catalogue. Expanded partnership for SyMRI 3D with joint marketing. SyMRI NEURO compatible with Philips SmartSpeed for accelerated imaging.
- Canon Medical SystemscoreJoint development project with Juntendo University Hospital and Canon Medical Systems for SyMRI 3D development. SyMRI compatible with Canon MRI scanners through this partnership.
- United ImagingminorPartnership agreement and first order received for SyMRI integration with United Imaging MRI systems.
- FujifilmminorSyMRI product available in Fujifilm's Synapse PACS solution for customers in Japan, providing additional distribution channel in Japanese market.
- SectraminorSyMRI sold through partnership agreements with Sectra for PACS integration.
- SimonMed ImagingcoreNorth American partnership for utilization of SyMRI technology across multiple SimonMed imaging sites. Expanded trials of synthetic MRI testing and expansion of availability.
- Laureate Institute for Brain ResearchminorIntegration of SyMRI to support neuropsychiatric research in mood and anxiety disorders using quantitative MRI measures.
- Mahajan ImagingminorCollaboration agreement for SyMRI utilization in India.
- Cincinnati Children's Hospital Medical CenterminorClinical collaboration using SyMRI in pediatric MRI examinations. Dr. Leach leading quantitative MRI implementation for brain development assessment.
- ProScan ImagingminorIntegration of SyMRI into clinical workflow at ProScan Imaging facilities.
- Combinostics OycoreAcquired January 2, 2025 for EUR 4.3 million to integrate Combinostics' cNeuro platform (cMRI, cDSI, cPET, cDAT) and strengthen AI-based neuroimaging capabilities. Jussi Mattila, former CTO of Combinostics, now CTO of SyntheticMR.
Scale indicators8 records
Recent moves8 records
Expansion highlights6 records
SyntheticMR competitors and assessment
Company assessmentBroad incumbents
- GE Healthcare: Global MRI OEM and SyntheticMR's flagship licensing partner — markets MAGiC (a customized version of SyMRI IMAGE) on SIGNA scanners. Directly comparable as a large-scale MRI hardware-and-software incumbent whose AI roadmap overlaps with SyntheticMR's quantitative imaging niche.
- Siemens Healthineers: Global MRI OEM and reseller of SyMRI NEURO via syngo.via Open Apps. Comparable as a broad incumbent offering AI-enabled imaging suites (AI-Rad Companion) that overlap with SyntheticMR's clinical-decision-support positioning.
- Philips Healthcare: Global MRI OEM with SyMRI integration through SmartSpeed AI-accelerated imaging and the third-party catalogue. Comparable as a broad incumbent whose AI imaging portfolio competes for the same radiology-department budgets.
- Canon Medical Systems: Global MRI OEM co-developing SyMRI 3D with Juntendo University Hospital and distributing SyMRI-compatible scanners. Comparable as a broad MRI incumbent whose AiCE deep-learning reconstruction competes with SyntheticMR's quantitative imaging narrative.
- Brainlab: German image-guided surgery and neuro-radiotherapy software company with growing AI imaging offerings for the brain. Comparable as a broader neuro-imaging software incumbent with adjacent quantitative imaging and decision-support capabilities.
- United Imaging Healthcare: Chinese MRI/CT OEM with a SyMRI integration partnership and growing AI imaging portfolio (uAI). Comparable as a broad incumbent expanding globally whose installed base and AI roadmap increasingly intersect with SyntheticMR's channel.
Direct peers
- Icometrix: Belgian specialist in AI-based brain MRI quantification (icobrain) for MS, dementia and traumatic brain injury. Direct peer because it offers MRI brain quantification and clinical decision support in the same neurology workflows SyntheticMR targets with SyMRI NEURO and cNeuro.
- Cortechs Labs: US-based developer of quantitative MRI post-processing software (NeuroQuant, LesionQuant) for brain volumetrics and lesion tracking. Direct peer because it sells quantitative MRI biomarkers into the same radiology/neurology decision-support workflow that SyMRI NEURO addresses.
Emerging players
- Subtle Medical: US-based AI medical imaging company focused on faster MRI acquisition (SubtleMR, SubtleSynth) using deep learning. Emerging peer because it addresses the same MRI throughput and workflow pain points SyntheticMR tackles through synthetic contrast imaging.
- QMENTA: Spain/US cloud-based neuroimaging platform providing quantitative analysis and trial-management tools for brain MRI. Emerging peer because it competes for AI-driven brain-imaging quantification and clinical-trial workflows that overlap with cNeuro and SyMRI NEURO.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
SyntheticMR social profiles
Digital presenceSyntheticMR compliance and trust
Trust signalCompliance4 records
SyntheticMR financial estimates
Financial estimateRevenue estimate
Valuation estimate
SyntheticMR leadership team
Management profileNumber of profiles
Profiles10 records
SyntheticMR subsidiaries and ownership
Company hierarchySubsidiaries5 records
SyntheticMR funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SyntheticMR M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SyntheticMR
What does SyntheticMR do?
SyntheticMR develops and markets SyMRI, a quantitative MRI software platform that produces multiple adjustable contrast-weighted images and absolute tissue property measurements (T1, T2, PD maps) plus automatic brain tissue and myelin segmentations from a single 5-minute MRI scan. The platform is sold in clinically focused packages (SyMRI NEURO for brain imaging, SyMRI MSK for knee and spine, SyMRI IMAGE / MAGiC standard package) and complemented by the cNeuro AI clinical decision-support platform (acquired from Combinostics Oy) for differential diagnosis of cognitive and neurodegenerative disorders.
Is SyntheticMR a public or private company?
SyntheticMR is a public company. It is classified as public and is currently operating.
When was SyntheticMR founded?
SyntheticMR was founded in 2007. It employs 11 to 50 people.
Where is SyntheticMR based?
SyntheticMR is headquartered in Linköping, Sweden, in the Europe region.
How does SyntheticMR make money?
Three revenue lines are on record. Software License Sales are the primary driver. The others are OEM Licensing (GE Healthcare - MAGiC) and acquisition Integration (Combinostics).
Who are SyntheticMR's main competitors?
Broad incumbents on record are GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Brainlab and United Imaging Healthcare. Direct peers are Icometrix and Cortechs Labs. Emerging players are Subtle Medical and QMENTA.
Does SyntheticMR have an API?
No public API is recorded for SyntheticMR.
What industry is SyntheticMR in?
SyntheticMR's product category is Medical Imaging Software (Quantitative MRI). Its primary akta.pro industry code is HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software, with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 62151 and its SIC code is 3841.